Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 1990 Jul;149(10):722-6.
doi: 10.1007/BF01959531.

Peroxisomal beta-oxidation defect with detectable peroxisomes: a case with neonatal onset and progressive course

Affiliations
Case Reports

Peroxisomal beta-oxidation defect with detectable peroxisomes: a case with neonatal onset and progressive course

P G Barth et al. Eur J Pediatr. 1990 Jul.

Abstract

A progressive demyelinating cerebral disorder is described in a normally-appearing female infant with neonatal seizures, progressive psychomotor deterioration, deafness, retinopathy, peripheral neuropathy and loss of myelin observed on magnetic resonance imaging (MRI) scanning. MRI also showed the absence of macroscopic neocortical dysplasia which is usually found in Zellweger syndrome (ZS). Adrenal cortical function was normal. The patient died at the age of 37 months. Extensive biochemical investigations of peroxisomal functions in the patient revealed an impairment of peroxisomal beta-oxidation resulting in elevated levels of very long (greater than C22) chain fatty acids in plasma and fibroblasts. Moreover, elevated plasma levels of intermediates of bile acid biosynthesis such as tri- and dihydroxycholestanoic acid were found. Other peroxisomal functions were normal. Immunoblotting of the peroxisomal beta-oxidation enzyme proteins in liver from the patient revealed normal responses with antisera against acyl-CoA oxidase, bifunctional protein and thiolase respectively. From these data we conclude that the patient had a deficiency of a single peroxisomal beta-oxidation enzyme at the level of either the bifunctional protein or peroxisomal thiolase with retained immunoreactivity against these enzymes.

PubMed Disclaimer

Similar articles

Cited by

References

    1. FEBS Lett. 1986 Feb 17;196(2):247-50 - PubMed
    1. J Neurol Sci. 1980 Mar;45(2-3):245-60 - PubMed
    1. Am J Pathol. 1982 Jul;108(1):100-11 - PubMed
    1. Clin Chim Acta. 1988 Feb 29;172(1):65-76 - PubMed
    1. Acta Neuropathol. 1976 Mar 15;34(2):115-23 - PubMed

Publication types